| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/25/2001 | EP1118663A1 Nucleic acids encoding chemotaxis inhibitory polypeptides |
| 07/25/2001 | EP1118660A1 Enzyme producing plasma protein fragment having effect of inhibiting cancer metastasis and plasma protein fragment fragmented by the enzyme |
| 07/25/2001 | EP1118331A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this method |
| 07/25/2001 | EP1118330A1 Interferon-alpha use in the treatment of Ewing's family of tumors |
| 07/25/2001 | EP1118323A2 Method of reducing morbidity and the risk of mortality |
| 07/25/2001 | EP1117840A1 Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant gpiiia and/or variant gpiib allele |
| 07/25/2001 | EP1117836A2 Expressionanalysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 07/25/2001 | EP1117833A1 A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers |
| 07/25/2001 | EP1117796A2 Calcium channel alpha-2/delta gene |
| 07/25/2001 | EP1117793A2 Secretory protein - zsig48 |
| 07/25/2001 | EP1117791A2 Cancer associated antigens and uses therefor |
| 07/25/2001 | EP1117785A1 Human kinesin-like motor protein |
| 07/25/2001 | EP1117778A2 Methods and compositions for inducing differentiation and apoptosis in cells that overexpress the notch protein |
| 07/25/2001 | EP1117776A1 ENZYMATIC SYNTHESIS OF ssDNA |
| 07/25/2001 | EP1117767A1 Immunomodulation by genetic modification of dendritic cells and b-cells |
| 07/25/2001 | EP1117765A2 Stem cells bearing an fgf receptor on the cell surface |
| 07/25/2001 | EP1117764A1 Primate embryonic stem cells with compatible histocompatibility genes |
| 07/25/2001 | EP1117762A1 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 07/25/2001 | EP1117687A2 Compositions and methods for wt1 specific immunotherapy |
| 07/25/2001 | EP1117684A1 Chemical structure with affinity for a phospholipid, and marker compound, diagnosis kit, and medicine comprising said structure |
| 07/25/2001 | EP1117679A2 Tumor antigens and ctl clones isolated by a novel procedure |
| 07/25/2001 | EP1117672A1 Antisense modulation of survivin expression |
| 07/25/2001 | EP1117665A1 Photosensitizers for photodynamic applications |
| 07/25/2001 | EP1117662A1 Benzimidazolinyl piperidines as cgrp ligands |
| 07/25/2001 | EP1117659A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/25/2001 | EP1117653A1 Chemical compounds |
| 07/25/2001 | EP1117649A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/25/2001 | EP1117648A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 07/25/2001 | EP1117643A1 New crystal modification iii of torasemide |
| 07/25/2001 | EP1117633A1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 07/25/2001 | EP1117628A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 07/25/2001 | EP1117444A2 Hydrogels and water soluble polymeric carriers for drug delivery |
| 07/25/2001 | EP1117441A2 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them |
| 07/25/2001 | EP1117440A1 Pharmaceutical compositions containing paclitaxel |
| 07/25/2001 | EP1117439A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 07/25/2001 | EP1117438A1 Tie2 antagonist antibodies |
| 07/25/2001 | EP1117430A1 Genes differentially expressed in cancer cells to design cancer vaccines |
| 07/25/2001 | EP1117428A2 Compositions and methods for inhibiting angiogenesis |
| 07/25/2001 | EP1117425A2 Methods for the treatment of non-thyroid disorders |
| 07/25/2001 | EP1117424A2 Null igf for the treatment of cancer |
| 07/25/2001 | EP1117423A2 Immortalized human keratinocyte cell line |
| 07/25/2001 | EP1117421A2 Methods for therapeutic vaccination |
| 07/25/2001 | EP1117420A1 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues |
| 07/25/2001 | EP1117419A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 07/25/2001 | EP1117418A1 Plant extracts for the treatment of increased bone resorption |
| 07/25/2001 | EP1117416A1 Plant extracts for the treatment of increased bone resorption |
| 07/25/2001 | EP1117398A2 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 07/25/2001 | EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 07/25/2001 | EP1117395A1 Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same |
| 07/25/2001 | EP1117393A2 Use of acylcarnitines as antitumour agents |
| 07/25/2001 | EP1117297A1 Synthetic analogs of ecteinascidin-743 |
| 07/25/2001 | EP1117296A1 Combination of bisphosphonate and tetracycline |
| 07/25/2001 | EP0889876B1 Meta-substituted phenylene sulphonamide derivatives |
| 07/25/2001 | EP0794955B1 Hindered n-oxide esters of rapamycin and their use as medicaments |
| 07/25/2001 | EP0752857B1 AN IMPROVED METHOD OF SYNTHESIS FOR 6,9-BIS (2-AMINOETHYL)AMINO]BENZO g]ISOQUINOLINE-5,10-DIONE AND ITS DIMALEATE SALT |
| 07/25/2001 | EP0649312B1 Anthracycline conjugates, their preparation and their use as antitumor agents |
| 07/25/2001 | EP0642357B1 Radiolabelled somatostatin |
| 07/25/2001 | EP0585444B1 Hepatoma treatment with somatostatin analogs |
| 07/25/2001 | CN1305527A Vasculogenesis correlation molecule |
| 07/25/2001 | CN1305497A Monoclonal antibodies directed against the G3BP protein and use |
| 07/25/2001 | CN1305496A Cyclic somatostatin analogs |
| 07/25/2001 | CN1305495A Peptide |
| 07/25/2001 | CN1305482A Artemisinin derivatives, method for preparation thereof and pharmaceutical compositions containing the same |
| 07/25/2001 | CN1305480A Pyrolo [2,3-d] pyrimidine compounds |
| 07/25/2001 | CN1305479A Pyrrolo [2,3-d] pyrmidine compounds |
| 07/25/2001 | CN1305478A Pyrazolopyrimidinone cGMP PDE 5 inhibitors for treatment of sexual dysfunction |
| 07/25/2001 | CN1305477A Azablicyclic 5-HT, receptor ligands |
| 07/25/2001 | CN1305473A N,N-disubstituded amide for inhibit binding of integrins to their receptors protein |
| 07/25/2001 | CN1305465A Aryl alkanoylpyridazines |
| 07/25/2001 | CN1305463A Substituted sulphonyl cyanamides, method for producing same and their use as medicament |
| 07/25/2001 | CN1305458A Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 07/25/2001 | CN1305457A Novel antiestrogens, method for production thereof and their pharmaceutical application |
| 07/25/2001 | CN1305386A Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor |
| 07/25/2001 | CN1305384A Immunomodulatory compositions of MMTV antigens and method of using same |
| 07/25/2001 | CN1305381A Cyclophosphamide coated tablets |
| 07/25/2001 | CN1304934A Antineoplastic medicine and its preparing process |
| 07/25/2001 | CN1304930A Arylsulfurylisooximino acid derivative |
| 07/25/2001 | CN1304724A Composition for preventing and treating osteoporosis and cancer and decreasing blood fat and its application |
| 07/25/2001 | CN1304687A Se-enriched cordyceps militaris tea and its preparing process |
| 07/25/2001 | CN1068792C Lycium chinese glycopeptide and its production process |
| 07/25/2001 | CN1068788C Anticancer and pain-releving paster |
| 07/25/2001 | CN1068782C Anti-cancer medicine with extracts from goldenrain and the preparation thereof |
| 07/24/2001 | US6265588 Use as pharmaceuticals; as an antigen for production of antibodies and in diagnosis and purification |
| 07/24/2001 | US6265578 Matrix metalloprotease inhibitors |
| 07/24/2001 | US6265564 Expressed ligand-vascular intercellular signalling molecule |
| 07/24/2001 | US6265562 Nucleotide sequences coding transcription factor; for the treatment and prevention of infection, tumors, leukemias, autoimmune disease, allergies, arthritis, inflammation, organ rejection, graft versus host disease and coagulation defects |
| 07/24/2001 | US6265560 Nucleotide sequences coding enzymatic polypeptide associated with signal transducton; for diagnosis, prevention, and treatment of inflammation, arthritis and physiological defects |
| 07/24/2001 | US6265550 Antibody; for use in the diagnosis, prevention, and treatment of cancer, inflammation, and insulin response defects |
| 07/24/2001 | US6265547 Polypeptide for use in diagnosis, treatment, and prevention of cancer, nervous system disorders |
| 07/24/2001 | US6265543 Polypeptide for the treatment of eye disorders, tumors, cancer, psoriasis, trauma, psychological, burns and ulcers |
| 07/24/2001 | US6265448 administering toremifene |
| 07/24/2001 | US6265446 Antiinflammatory agents; autoimmune diseases |
| 07/24/2001 | US6265425 Side effect reduction; retinoic acid metabolism blocking agent |
| 07/24/2001 | US6265423 Skin disorders; anticancer agents |
| 07/24/2001 | US6265422 Anticancer agents; cardiovascular disorders |
| 07/24/2001 | US6265413 Water solubility; anticarcinogenic agents |
| 07/24/2001 | US6265411 Oxindole derivatives |
| 07/24/2001 | US6265410 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 07/24/2001 | US6265403 Angiogenesis inhibitors |
| 07/24/2001 | US6265399 Alkylation; cyclization |